Evidence map›Paper›PMID 32966789›Full record

ArticleCell reports2020

Chromatin Landscape Underpinning Human Dendritic Cell Heterogeneity.

Rebecca Leylek, Marcela Alcántara-Hernández, Jeffrey M Granja, Michael Chavez, Kimberly Perez, Oscar R Diaz, Rui Li, Ansuman T Satpathy, Howard Y Chang, Juliana Idoyaga

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Human CD34Frontiers in immunology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Ly6DNature communications · 2022
    Article
  13. Article
  14. Article
  15. Single-cell analysis of myeloid cells in HPVFrontiers in immunology · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rebecca LeylekDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Marcela Alcántara-HernándezDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Jeffrey M GranjaBiophysics Program, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA 94305, USA.
Michael ChavezDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Kimberly PerezDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Oscar R DiazDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Rui LiCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA 94305, USA.
Ansuman T SatpathyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Howard Y ChangCenter for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA 94305, USA; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Juliana IdoyagaDepartment of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Immunology Program, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: jidoyaga@stanford.edu.
Stanford University · USHoward Hughes Medical Institute · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Center for Personal Dynamic RegulomesRM1HG007735 · NHGRI · STANFORD UNIVERSITY · PI CHANG, HOWARD Y · 2019 to 2023
$13.8M
Harnessing human dendritic cell subsets for the design of novel immunotherapiesDP2AR069953 · NIAMS · STANFORD UNIVERSITY · PI IDOYAGA, JULIANA · 2015 to 2015
$2.4M
CyTOFS10OD016318 · OD · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2013 to 2013
$600k
Four Laser, 18 Color Cell Sorter in the SSFFS10RR025518 · NCRR · STANFORD UNIVERSITY · PI HERZENBERG, LEONARD A · 2009 to 2009
$500k
Single cell epigenomics in cancer immunity and immunotherapyK08CA230188 · NCI · STANFORD UNIVERSITY · PI SATPATHY, ANSUMAN · 2018 to 2020
$448k
NCI NIH HHS K08 CA230188NCRR NIH HHS S10 RR025518NHGRI NIH HHS RM1 HG007735NIAMS NIH HHS DP2 AR069953NIH HHS S10 OD016318
6 · The paper itself

Abstract

Human dendritic cells (DCs) comprise subsets with distinct phenotypic and functional characteristics, but the transcriptional programs that dictate their identity remain elusive. Here, we analyze global chromatin accessibility profiles across resting and stimulated human DC subsets by means of the assay for transposase-accessible chromatin using sequencing (ATAC-seq). We uncover specific regions of chromatin accessibility for each subset and transcriptional regulators of DC function. By comparing plasmacytoid DC responses to IFN-I-producing and non-IFN-I-producing conditions, we identify genetic programs related to their function. Finally, by intersecting chromatin accessibility with genome-wide association studies, we recognize DC subset-specific enrichment of heritability in autoimmune diseases. Our results unravel the basis of human DC subset heterogeneity and provide a framework for their analysis in disease pathogenesis.

Indexed as

AdultCD40 LigandChromatinChromatin Immunoprecipitation SequencingDendritic CellsGene Expression RegulationGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMiddle AgedPolymorphism, Single NucleotideRepressor ProteinsRisk FactorsScleroderma, SystemicTranscription, GeneticYoung AdultCD40 LigandChromatinRepressor ProteinsZBTB18 protein, humanASDCsATAC-seqAXL+ DCscDC1cDC2dendritic cellshumanIFN-ImonocytespDCsplasmacytoid dendritic cellstDCstransitional dendritic cells

Identifiers

PMID32966789
PMCPMC7546547
OpenAlexW3088220553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.